Document Type
Article
Department
Internal Medicine (East Africa); Brain and Mind Institute
Abstract
Background: Efficacy of Implantable Cardioverter-Defibrillator (ICD) implantation in both primary and secondary prevention of Sudden Cardiac Death (SCD) in at-risk population is well established. ICD implantation rates remain low particularly in Africa with a paucity of data regarding factors associated with non-uptake.
Objectives:The primary study objective was to determine the factors associated with non-uptake of ICD among heart failure (HF) patients with reduced ejection fraction (EF
Methods: This was a retrospective study among HF patients eligible for ICD implantation evaluated between 2018 to 2020. Comparison between ICD recipient and non-recipient categories was made to establish determinants of non-uptake.
Results: Of 206 eligible patients, only 69 (33.5%) had an ICD. Factors independently associated with non-uptake were lack of private insurance (42.3% vs 63.8%; p = 0.005), non-cardiology physician (16.1% vs 5.8%; p = 0.045) and non-ischemic cardiomyopathy (54.7% vs 36.4% p = 0.014). The most common (75%) reason for ICD refusal was inability to pay for the device.
Conclusion: ICDs are underutilized among eligible HF with reduced EF patients in Kenya. The majority of patients without ICD had no private insurance, had non-ischemic cardiomyopathy and non-cardiology primary physician. Early referral of HF with reduced EF patients to HF specialists to optimize guideline-directed medical therapy and make ICD recommendation is needed.
Publication (Name of Journal)
Global Heart
DOI
https:// doi.org/10.5334/gh.1346
Recommended Citation
Oluoch, E.,
Shah, J.,
Mohamed, J.,
Varwani, M.,
Ngunga, M.
(2024). Factors associated with non-uptake of implantable cardioverter-defibrillator (ICD) among eligible patients at a tertiary hospital in Kenya. Global Heart, 19(1), 1-9.
Available at:
https://ecommons.aku.edu/eastafrica_fhs_mc_intern_med/431
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.